IBDEI163 ; ; 17-FEB-2016
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;JUN 29, 2015
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,19850,2)
 ;;=^5000617
 ;;^UTILITY(U,$J,358.3,19851,0)
 ;;=A59.03^^84^925^96
 ;;^UTILITY(U,$J,358.3,19851,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,19851,1,3,0)
 ;;=3^Trichomonal Cystitis & Urethritis
 ;;^UTILITY(U,$J,358.3,19851,1,4,0)
 ;;=4^A59.03
 ;;^UTILITY(U,$J,358.3,19851,2)
 ;;=^5000349
 ;;^UTILITY(U,$J,358.3,19852,0)
 ;;=E87.6^^84^925^57
 ;;^UTILITY(U,$J,358.3,19852,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,19852,1,3,0)
 ;;=3^Hypokalemia
 ;;^UTILITY(U,$J,358.3,19852,1,4,0)
 ;;=4^E87.6
 ;;^UTILITY(U,$J,358.3,19852,2)
 ;;=^60610
 ;;^UTILITY(U,$J,358.3,19853,0)
 ;;=F52.0^^84^925^56
 ;;^UTILITY(U,$J,358.3,19853,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,19853,1,3,0)
 ;;=3^Hypoactive Sexual Desire Disorder
 ;;^UTILITY(U,$J,358.3,19853,1,4,0)
 ;;=4^F52.0
 ;;^UTILITY(U,$J,358.3,19853,2)
 ;;=^5003618
 ;;^UTILITY(U,$J,358.3,19854,0)
 ;;=F52.22^^84^925^93
 ;;^UTILITY(U,$J,358.3,19854,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,19854,1,3,0)
 ;;=3^Sexual Arousal Disorder,Female
 ;;^UTILITY(U,$J,358.3,19854,1,4,0)
 ;;=4^F52.22
 ;;^UTILITY(U,$J,358.3,19854,2)
 ;;=^5003621
 ;;^UTILITY(U,$J,358.3,19855,0)
 ;;=F52.8^^84^925^94
 ;;^UTILITY(U,$J,358.3,19855,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,19855,1,3,0)
 ;;=3^Sexual Dysfnct Not d/t Substance/Known Physiological Cond
 ;;^UTILITY(U,$J,358.3,19855,1,4,0)
 ;;=4^F52.8
 ;;^UTILITY(U,$J,358.3,19855,2)
 ;;=^5003624
 ;;^UTILITY(U,$J,358.3,19856,0)
 ;;=F52.21^^84^925^33
 ;;^UTILITY(U,$J,358.3,19856,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,19856,1,3,0)
 ;;=3^Erectile Disorder,Male (Psychogenic)
 ;;^UTILITY(U,$J,358.3,19856,1,4,0)
 ;;=4^F52.21
 ;;^UTILITY(U,$J,358.3,19856,2)
 ;;=^5003620
 ;;^UTILITY(U,$J,358.3,19857,0)
 ;;=I12.9^^84^925^55
 ;;^UTILITY(U,$J,358.3,19857,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,19857,1,3,0)
 ;;=3^Hypertensive Kidney Disease Chronic w/ Stg 1-4
 ;;^UTILITY(U,$J,358.3,19857,1,4,0)
 ;;=4^I12.9
 ;;^UTILITY(U,$J,358.3,19857,2)
 ;;=^5007066
 ;;^UTILITY(U,$J,358.3,19858,0)
 ;;=N04.9^^84^925^69
 ;;^UTILITY(U,$J,358.3,19858,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,19858,1,3,0)
 ;;=3^Nephrotic Syndrome w/ Unspec Morphologic Changes
 ;;^UTILITY(U,$J,358.3,19858,1,4,0)
 ;;=4^N04.9
 ;;^UTILITY(U,$J,358.3,19858,2)
 ;;=^5015540
 ;;^UTILITY(U,$J,358.3,19859,0)
 ;;=N02.9^^84^925^50
 ;;^UTILITY(U,$J,358.3,19859,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,19859,1,3,0)
 ;;=3^Hematuria w/ Unspec Morphologic Changes,Recurrent & Persistent
 ;;^UTILITY(U,$J,358.3,19859,1,4,0)
 ;;=4^N02.9
 ;;^UTILITY(U,$J,358.3,19859,2)
 ;;=^5015520
 ;;^UTILITY(U,$J,358.3,19860,0)
 ;;=N06.9^^84^925^86
 ;;^UTILITY(U,$J,358.3,19860,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,19860,1,3,0)
 ;;=3^Proteinuria Isolated w/ Unspec Morphologic Lesion
 ;;^UTILITY(U,$J,358.3,19860,1,4,0)
 ;;=4^N06.9
 ;;^UTILITY(U,$J,358.3,19860,2)
 ;;=^5015558
 ;;^UTILITY(U,$J,358.3,19861,0)
 ;;=N05.9^^84^925^66
 ;;^UTILITY(U,$J,358.3,19861,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,19861,1,3,0)
 ;;=3^Nephritic Syndrome w/ Unspec Morphologic Changes
 ;;^UTILITY(U,$J,358.3,19861,1,4,0)
 ;;=4^N05.9
 ;;^UTILITY(U,$J,358.3,19861,2)
 ;;=^5134086
 ;;^UTILITY(U,$J,358.3,19862,0)
 ;;=N07.9^^84^925^68
 ;;^UTILITY(U,$J,358.3,19862,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,19862,1,3,0)
 ;;=3^Nephropathy Hereditary w/ Unspec Morphologic Lesions
 ;;^UTILITY(U,$J,358.3,19862,1,4,0)
 ;;=4^N07.9
 ;;^UTILITY(U,$J,358.3,19862,2)
 ;;=^5015568
 ;;^UTILITY(U,$J,358.3,19863,0)
 ;;=N15.9^^84^925^92
 ;;^UTILITY(U,$J,358.3,19863,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,19863,1,3,0)
 ;;=3^Renal Tubulo-Interstitial Disease,Unspec
